Health news
The Food and Drug Administration (FDA) has approved Recorlev® (levoketoconazole) for the treatment of endogenous hypercortisolemia in adults with Cushing syndrome for whom surgery is not an option or has not been curative. Recorlev is…
Skytrofa® (lonapegsomatropin-tcgd) is now available for the treatment of patients 1 year of age and older weighing at least 11.5kg with growth failure due to inadequate secretion of endogenous growth hormone. Skytrofa is a long-acting…
The Food and Drug Administration has approved Skytrofa® (lonapegsomatropin-tcgd) to treat patients 1 year of age and older weighing at least 11.5kg and have a growth failure due to inadequate secretion of endogenous growth hormone.…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021